The Supreme Court decision that’s shaking up biotech

In biotech, your company is only as good as its intellectual property. And the Supreme Court on Monday left a whole lot of biotech entrepreneurs fearful that their inventions may not be worth all that much after all. The justices spooked the industry by declining to hear an appeal from Sequenom, a California company that markets a […]

Read More

Post-Brexit, will the European Medicines Agency be homeless?

Britain’s popular vote to leave the European Union seems likely to cause major disruptions for the drug approval process in the UK and across the channel in mainland Europe, analysts said Friday. There were also predictions that medical research funding will take a hit. “The future structure of medicine regulation in Europe is now thrown […]

Read More

Stem cell factory opens door for trials of personalized diabetes treatment

In a step that could lead to a new diabetes treatment, several Boston-area hospitals have teamed up with the Harvard Stem Cell Institute and biotech Semma Therapeutics to make personalized cell-based therapies and organize clinical trials. It is one of several initiatives around the country aimed at manufacturing cell-derived treatments, as the hope for such […]

Read More

Top exec defends Google biotech spinoff, promises ‘amazing’ breakthroughs

spinoff Verily Life Sciences, rose to the defense of the firm Wednesday after a series of STAT reports that raised concerns about its leadership and the science behind its signature projects. “We’re very, very confident of not only (Verily’s) approaches, but also the controls, reviews, and processes that will ultimately produce some amazing medical breakthroughs,” […]

Read More

Inside the sci-fi world of growing human tissue and organs in the lab

Inside a North Carolina lab, row upon row of plastic bioreactor bags pulsate gently to the beat of an artificial heart. Within each bag, a lab-forged blood vessel slowly expands, feeding off a primordial cocktail of vitamins and proteins. The blood vessels start as individual cells, placed inside a sinewy scaffold. Weeks later, they’ve grown […]

Read More

Google spinoff’s top doctor responds to skepticism about bold health projects

SAN FRANCISCO — The chief medical officer of Verily Life Sciences, Google’s biotech spinoff, responded Tuesday to a recent STAT article that detailed doubts by prominent scientists about the chances her company’s highest-profile projects would succeed. Dr. Jessica Mega said Verily was trying to build a “creative environment” that allowed for failures as well as […]

Read More

Big Biotech is here — and it’s starting to look a lot like Big Pharma

Move over, Big Pharma. Big Biotech is coming for you. As drug developers and investors from around the world gather in San Francisco this week for the annual BIO International Convention, a new look at the biotech industry shows the biggest players are starting to behave more and more like pharmaceutical giants. There are 17 biotech companies […]

Read More